NCT02530242View on ClinicalTrials.gov

Carbon Monoxide Measurement to Screen for Sickle Cell Disease

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Sickle Cell Anemia
Interventions
DEVICE

End-tidal Carbon Monoxide Subjects

ETCO monitor will be used to measure CO levels in subjects and controls.

DEVICE

End-tidal Carbon Monoxide Controls

ETCO monitor will be used to measure CO levels in subjects and controls.

All Listed Sponsors
collaborator

Capnia, Inc.

INDUSTRY

lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT02530242 - Carbon Monoxide Measurement to Screen for Sickle Cell Disease | Biotech Hunter | Biotech Hunter